MedPath

Physiological Effects of APRVplus and TCAV in ARDS

Not Applicable
Completed
Conditions
ARDS (Acute Respiratory Distress Syndrome)
Registration Number
NCT06748807
Lead Sponsor
West China Hospital
Brief Summary

In previous studies, airway pressure release ventilation (APRV) has been proven to be an important respiratory support method for ARDS patients, and various APRV ventilation strategies have been proposed. This study aims to compare the physiological effects of two types of APRV ventilation strategy, Early Pathophysiology-driven APRV (APRVplus) and Time-Controlled Adaptive Ventilation (TCAV), through randomized crossover trials, providing evidence for clinical application and further research on APRV.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
20
Inclusion Criteria
  • intubated and mechanically ventilated patients
  • meet the 2023 global new definition of ARDS
Exclusion Criteria
  • Pregnancy
  • The expected duration of mechanical ventilation was less than 48 hours
  • Intracranial hypertension (suspected or confirmed)
  • Neuromuscular disorders that are known to prolong the need for mechanical ventilation
  • Known or suspected chronic obstructive pulmonary disease(COPD)
  • Terminal stage of disease
  • Pneumothorax (drained or not)at enrollment
  • Treatment with extracorporeal support (ECMO) at enrollment
  • There was a lack of commitment to life support

Study & Design

Study Type
INTERVENTIONAL
Study Design
CROSSOVER
Primary Outcome Measures
NameTimeMethod
△PL(PLThigh - PLTlow)during the mechanical ventilation procedure

Transpulmonary pressure swings (△PL) equal to PLThigh - PLTlow

Secondary Outcome Measures
NameTimeMethod
EtCO2during the mechanical ventilation procedure

end-tidal carbon dioxide

GIduring the mechanical ventilation procedure

global inhomogeneity

PaO2(mmHg)during the mechanical ventilation procedure

the arterial partial pressure of oxygen

Trial Locations

Locations (1)

West China Hospital, Sichuan University

🇨🇳

Chengdu, Sichuan, China

© Copyright 2025. All Rights Reserved by MedPath